{"id":"W3213547762","doi":"10.1182/blood-2021-151105","title":"Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in Patients with CD30-Expressing Peripheral T-Cell Lymphomas","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Medicine; Etoposide; Internal medicine; Anaplastic large-cell lymphoma; Vincristine; CHOP; CD30; Oncology; Cyclophosphamide; Chemotherapy regimen; Chemotherapy; Prednisone; Autologous stem-cell transplantation; Lymphoma; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006133968,0.0004060955,0.0009551407,0.0002019393,0.0003178738,0.0004568706,0.0003692264,0.0004587576,0.001141681],"category_scores_gemma":[0.0005804672,0.0002666901,0.0005203392,0.000292639,0.0003136066,0.0004017749,0.0002647712,0.0007983894,0.0002419397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005886601,"about_ca_system_score_gemma":0.0007184874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006530312,"about_ca_topic_score_gemma":0.001321114,"domain_scores_codex":[0.9997613,0.00009714731,0.00002477047,0.00005147723,0.00002149815,0.0000438604],"domain_scores_gemma":[0.9995995,0.000068315,0.00007153167,0.00001672436,0.00001613178,0.0002278394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6221707,0.01861524,0.1321515,0.001223952,0.001087211,0.002028225,0.0004466813,0.003254666,0.0371349,0.0002478418,0.002298141,0.1793409],"study_design_scores_gemma":[0.1165645,0.6662459,0.198977,0.0001890291,0.001017028,0.003100666,0.0002013007,0.003715922,0.005461108,0.0002193904,0.004272028,0.00003601747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976326,0.001462373,0.0001309806,0.00006856804,0.00001921219,0.0002533433,0.0001037581,0.0000152121,0.0003138437],"genre_scores_gemma":[0.9986914,0.0004284555,0.0002560307,0.0001049771,0.0000329603,0.0001772806,0.0001581235,0.000002244727,0.0001484995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001141681,"threshold_uncertainty_score":0.00427103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004026462495773129,"score_gpt":0.200203021382474,"score_spread":0.1961765588867009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}